Liquidation07486063Private limited companyLondon

REVIRAL LIMITED

Significant control: Pfizer Specialty UK Limited (75–100%)

In liquidationThe company is being wound up. A liquidator deals with its affairs, assets and creditors' claims. Status as shown on the Companies House register at 31 August 2026; it may have changed since. Check the live record.

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Reviral Limited: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Reviral Limited sell?

Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy

Summary

Generated from filed data · no estimates

REVIRAL LIMITED is a liquidation private limited company (company number 07486063) incorporated on 10 January 2011, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Accounts are on file at Companies House (full) but not yet parsed into this record.

There are 603 companies in research and experimental development on biotechnology in London with filed accounts; the median reports net assets of £440 and is 6 years old.

Ownership and control

1 active · 4 other

Pfizer Specialty Uk Limited
corporate entity, England · since 9 June 2022
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
75–100%
persons with significant control statement · since 10 January 2017 · ceased 13 July 2018
Biodiscovery 4 Fpci
corporate entity, France · since 18 July 2017 · ceased 25 September 2019
- owns 25–50% of shares
- holds 25–50% of voting rights
25–50%
Orbimed Advisors Llc
corporate entity, United States Of America · since 18 July 2017 · ceased 25 September 2019
- owns 25–50% of shares
- holds 25–50% of voting rights
25–50%
persons with significant control statement · since 23 January 2020 · ceased 9 June 2022

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

Key dates

Incorporated: 10 January 201115 yrs ago
First accounts due: 10 October 20125127 days overdue
Confirmation statement due: 24 January 2027in 92 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

Activity

SIC 72110: Research and experimental development on biotechnology
Accounts type: Full

Financials

No accounts on record

Accounts exist on the register but their figures are not in this dataset yet.

Filing and accounts signals

Facts from the register · no rating

Incorporated five or more years agoIncorporated 10 January 2011
Register status is not ActiveLiquidation

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

Timeline

Newest first

24 Jan 2027Confirmation statement duein 92 days
10 Oct 2012First accounts due5127 days overdue
10 Jan 2011Incorporated

Similar companies in London

Same activity (research and experimental development on biotechnology), closest in incorporation date

All companies incorporated on 10 January 2011 · in Jan 2011.

Reminders for REVIRAL LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.